¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"B23"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
B23.0
Acute HIV infection syndrome
±Þ¼º HIV°¨¿° ÁõÈıº
B23.2
HIV disease resulting in haematological and immunological abnormalities, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Ç÷¾×ÇÐÀû ¹× ¸é¿ªÇÐÀû ÀÌ»óÀ» À¯¹ßÇÑ HIVº´
B23.8
HIV disease resulting in other specified conditions
±âŸ ¸í½ÃµÈ º´Å¸¦ À¯¹ßÇÑ HIVº´
B23.1
HIV disease resulting in(persistent) generalized lymphadenopathy
Àü½Å(Áö¼Ó¼º) ¸²ÇÁÀýº´ÁõÀ» À¯¹ßÇÑ HIVº´
B23
Human immunodeficiency virus [HIV] disease resulting in other conditions
±âŸ º´Å¸¦ À¯¹ßÇÑ ÀÎü¸é¿ª°áÇ̹ÙÀÌ·¯½ºº´
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½